Frank Clyburn $MRK SEC Form 4 Insider Trading

Frank Clyburn has filed a total of 1 insider trades in $MRK since 2021. Their most recent trade was a sale of 39,762 shares, made on Nov 01, 2021. Their largest trade was a sale of 39,762 shares, made on Nov 01, 2021. We estimate that they now own 97,095 shares of $MRK, worth an estimated $9.8 million.

Insider Trading at $MRK

There have been a total of 87 insider trades reported at $MRK since 2021, with 409 shares purchased and 5.1 million shares sold. The most active insider traders in $MRK stock have been Kenneth C Frazier, Steven Mizell, and Joseph Romanelli. The most recent trade was a sale of 38,291 shares reported by Caroline Litchfield (EVP & CFO), made on Feb 14, 2024.

$MRK Executives and Stock Owners with Insider Trades

• Kenneth C Frazier, Executive Chair

• Steven Mizell, EVP, Chief HR Officer

• Joseph Romanelli, President, Human Health Int?l

• Sanat Chattopadhyay, Exe V-P & Pres. MMD

• Richard R. Deluca, EVP&Pres, Merck Animal Heallth

• Jennifer Zachary, EVP, General Counsel

• Johannes Jacobus Oosthuizen, President, U.S. Market

• Robert M Davis, Chairman, CEO & President

• Rita A Karachun, Sr. VP Fince-Global Controller

• Robert M Davis, CEO & President

• Caroline Litchfield, EVP & CFO

• David Michael Williams, EVP,Chief Info&Digital Officer

• Dean Y Li, Executive VP & President, MRL

• Frank Clyburn, EVP & Pres ? Human Health

• Julie L. Gerberding, EVP, Chief Patient Officer

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.